国产成人嫩模一区二区|超级黄色网页|兔子先生tz|麻豆文化传媒网站官网污|在线播放欧美日韩精品|爱豆影视传媒免费下载|蜜桃影像传媒av剧情|麻豆文化传媒APP最新iOS|陈可心倩女幽魂爱豆传媒|91国视频产,国产传媒播放,想看三级片,网红吃瓜黑料爆料网反差

Wei Wu, Ph.D.

Senior Principal Investigator

Email: [email protected]

Research Interests

AI-driven precision brain health and clinical translation, brain signal processing, machine learning.

 

Education

2006–2012 Ph.D. in Biomedical Engineering, Tsinghua University (Joint Program with MIT)

2003–2006 M.S. in Biomedical Engineering, Tsinghua University

1999–2003 B.S. in Information Engineering, Nanjing University of Posts and Telecommunications

 

Professional Experience

2024–Present Senior Principal Investigator, Songjiang Research Institute, Shanghai Jiao Tong University School of Medicine

2020–2024 Co-Founder and Chief Data Science Officer, Alto Neuroscience (NYSE-listed)

2012–2019 Associate Professor & Professor, School of Automation Science and Engineering, South China University of Technology

 

Academic Achievements and Awards

Dr. Wei Wu is a senior principal investigator with extensive experience in both academia and industry. As a National High-Level Overseas Talent, he has been recognized with the First Prize of Guangdong Provincial Natural Science Award. He currently serves as a member of the IEEE Technical Committee on Biomedical Signal Processing and as an editorial board member for several top-tier international journals, including IEEE Transactions on Affective Computing and IEEE Journal of Biomedical and Health Informatics.

As the corresponding or first author, Dr. Wu has published dozens of high-impact papers in leading journals in biomedical engineering and artificial intelligence, including Nature Biotechnology, Nature Biomedical Engineering, Nature Mental Health, Science Translational Medicine, IEEE Transactions on Pattern Analysis and Machine Intelligence, and IEEE Signal Processing Magazine. His work has made significant contributions to EEG signal analysis algorithms and biomarker research for psychiatric disorder diagnosis and treatment.

Dr. Wu is also the Co-Founder and former Chief Data Science Officer of Alto Neuroscience, a NYSE-listed precision psychiatry company. He developed the first AI-driven biomarker translation platform for psychiatric diagnosis and co-led multiple clinical trials for novel psychiatric drugs. His research successfully identified and prospectively validated AI biomarkers for treatment response prediction based on brain circuits, pioneering the application of precision medicine in psychiatry.

 

 



Wu Wei


    1. AI-Driven Precision Brain Health and Clinical Translation, including:

    Early Prediction of conversion to schizophrenia for the clinical high risk (CHR) population

    Early screening and intervention for adolescent depression

    Precision diagnosis and treatment of sleep disorder-related brain diseases

    1. Brain Signal Processing and Machine Learning, including:

    Brain signal decoding algorithms

    EEG/MEG source localization algorithms